GMO U.S. Value ETF (NYSEARCA:GMOV – Get Free Report) was the target of a large decrease in short interest in June. As of June 30th, there was short interest totaling 8,785 shares, a decrease of 35.4% from the June 15th total of 13,609 shares. Approximately 0.3% of the company’s shares are short sold. Based on an average trading volume of 15,506 shares, the short-interest ratio is presently 0.6 days.
GMO U.S. Value ETF Stock Performance
Shares of NYSEARCA:GMOV opened at $31.05 on Friday. The firm’s 50 day simple moving average is $30.16 and its 200-day simple moving average is $29.15. GMO U.S. Value ETF has a one year low of $24.79 and a one year high of $31.29. The firm has a market cap of $105.57 million, a PE ratio of 12.08 and a beta of 0.65.
Institutional Inflows and Outflows
Several institutional investors have recently bought and sold shares of the company. Fifth Third Bancorp bought a new stake in GMO U.S. Value ETF during the 1st quarter valued at $84,000. Pathway Financial Advisors LLC bought a new position in shares of GMO U.S. Value ETF during the 2nd quarter worth $246,000. Kestra Private Wealth Services LLC purchased a new position in shares of GMO U.S. Value ETF during the first quarter valued at $333,000. Aspen Investment Management Inc purchased a new position in shares of GMO U.S. Value ETF during the fourth quarter valued at $333,000. Finally, RPS Advisory Solutions LLC bought a new stake in shares of GMO U.S. Value ETF in the fourth quarter valued at about $484,000.
GMO U.S. Value ETF Company Profile
The GMO US Value ETF (GMOV) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, investing primarily in US equity securities. The fund seeks to identify undervalued US stocks using proprietary quantitative methods, capitalizing on perceived market dislocations GMOV was launched on Oct 28, 2024 and is issued by GMO.
Featured Stories
- Five stocks we like better than GMO U.S. Value ETF
- Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop
- Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs?
- The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story
- Why Intuitive Surgical’s Strong Quarter Still Spooked Investors
Receive News & Ratings for GMO U.S. Value ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GMO U.S. Value ETF and related companies with MarketBeat.com's FREE daily email newsletter.
